Pearson J. Michael 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Apr 16, 2012
Insider Transaction Report
Form 4
Pearson J. Michael
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock, no par values
2012-04-12−7,294→ 6,590,307 total - Exercise/Conversion
Common Stock, no par values
2012-04-12+502,998→ 6,597,601 total
Footnotes (3)
- [F1]Awarded 502,998 Restricted Share Units ("RSUs) based on a previous RSU award granted with performance vesting and with the right to receive one to three common shares if the award met certain TSR requirements.
- [F2]This number represents common shares purchased by the Reporting Person, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1.
- [F3]Represents common shares withheld to satisfy certain tax obligations at the time of release.